ALLOGENE THERAPEUTICS, INC. — TTAB Proceedings
ALLOGENE THERAPEUTICS, INC. is a party to 7 TTAB proceedings.
Proceedings
- Proceeding 92086120 — Cancellations, Terminated (filed 2024-08-30) against CRISPR Therapeutics AG as defendant
- Proceeding 91247247 — Oppositions, Terminated (filed 2019-03-27) against CRISPR Therapeutics AG as defendant
- Proceeding 91247245 — Oppositions, Terminated (filed 2019-03-27) against CRISPR Therapeutics AG as defendant
- Proceeding 91283879 — Oppositions, Terminated (filed 2023-03-09) against CRISPR Therapeutics AG as defendant
- Proceeding 91247175 — Oppositions, Terminated (filed 2019-03-25) against Atara Biotherapeutics, Inc. as defendant
- Proceeding 91247177 — Oppositions, Terminated (filed 2019-03-25) against Atara Biotherapeutics, Inc. as defendant
- Proceeding 91283322 — Oppositions, Terminated (filed 2023-02-08) against Atara Biotherapeutics, Inc. as defendant
Marks in These TTAB Matters
- ALLOCAR T — proceeding 92086120 (Defendant)
- ALLOCAR — proceeding 91283879 (Defendant)
- ALLOCAR — proceeding 91283322 (Defendant)
- AUTOCAR T — proceeding 91247247 (Defendant)
- ALLOCAR T — proceeding 91247245 (Defendant)
- ALLOCAR T — proceeding 91247175 (Defendant)
- AUTOCAR T — proceeding 91247177 (Defendant)
Recent Live Filings
- TURBOCAR — Pending, filed 2026-02-26
- DAGGER — Registered, filed 2022-11-22
- TURBOCAR — Pending, filed 2022-10-27
- CAR T TOGETHER MAKING ALLOGENEIC CAR T A REALITY FOR PATIENTS — Registered, filed 2022-08-05
- CAR T TOGETHER — Registered, filed 2022-08-05
- Trademark 88137747 — Registered, filed 2018-09-30
- Trademark 88137748 — Registered, filed 2018-09-30
- ALLOGENE THERAPEUTICS — Registered, filed 2018-09-28
- ALLOGENE THERAPEUTICS — Registered, filed 2018-09-28
- ALLOGENE THERAPEUTICS — Registered, filed 2018-09-28
- ALLOGENE THERAPEUTICS — Registered, filed 2018-09-28
Common TTAB Counterparties
- CRISPR Therapeutics AG — 4 proceedings
- Atara Biotherapeutics, Inc. — 3 proceedings
Recent TTAB Timeline
- 2025-11-17: 92086120 — TERMINATED involving CRISPR Therapeutics AG
- 2025-11-17: 92086120 — COMMR ORDER CANCELLING REG involving CRISPR Therapeutics AG
- 2025-09-29: 92086120 — BOARD'S DECISION: GRANTED involving CRISPR Therapeutics AG
- 2025-06-30: 92086120 — P'S MOTION FOR SUMMARY JUDGMENT involving CRISPR Therapeutics AG
- 2025-06-03: 91247245 — TERMINATED involving CRISPR Therapeutics AG
- 2025-06-03: 91247245 — BOARD'S DECISION: SUSTAINED involving CRISPR Therapeutics AG
- 2025-06-03: 91247247 — TERMINATED involving CRISPR Therapeutics AG
- 2025-06-03: 91247247 — BOARD'S DECISION: SUSTAINED involving CRISPR Therapeutics AG
- 2025-06-03: 92086120 — PROCEEDINGS RESUMED involving CRISPR Therapeutics AG
- 2025-04-30: 91247245 — P MOT FOR DEFAULT JUDGMENT involving CRISPR Therapeutics AG
- 2025-04-30: 91247245 — P CHANGE OF CORRESP ADDRESS involving CRISPR Therapeutics AG
- 2025-04-30: 91247247 — P MOT FOR DEFAULT JUDGMENT involving CRISPR Therapeutics AG
- 2025-04-30: 91247247 — P CHANGE OF CORRESP ADDRESS involving CRISPR Therapeutics AG
- 2025-04-30: 92086120 — P MOT FOR DEFAULT JUDGMENT involving CRISPR Therapeutics AG
- 2025-04-30: 92086120 — P CHANGE OF CORRESP ADDRESS involving CRISPR Therapeutics AG
- 2025-03-13: 91247247 — P MOT TO AMEND PLEADING/AMENDED PLEADING involving CRISPR Therapeutics AG
- 2025-03-04: 91247245 — SUBMITTED ON BRIEF involving CRISPR Therapeutics AG
- 2025-03-04: 91247247 — SUBMITTED ON BRIEF involving CRISPR Therapeutics AG
- 2025-03-04: 92086120 — SUBMITTED ON BRIEF involving CRISPR Therapeutics AG
- 2024-10-29: 91247245 — P MOT TO CONSOLIDATE involving CRISPR Therapeutics AG
- 2024-10-29: 92086120 — P MOT TO CONSOLIDATE involving CRISPR Therapeutics AG
- 2024-10-09: 92086120 — ANSWER involving CRISPR Therapeutics AG
- 2024-08-30: 91247245 — P MOT TO AMEND PLEADING/AMENDED PLEADING involving CRISPR Therapeutics AG
- 2024-08-30: 91247247 — P CHANGE OF CORRESP ADDRESS involving CRISPR Therapeutics AG
- 2024-08-30: 92086120 — PENDING, INSTITUTED involving CRISPR Therapeutics AG
- 2024-08-30: 92086120 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving CRISPR Therapeutics AG
- 2024-08-30: 92086120 — FILED AND FEE involving CRISPR Therapeutics AG
- 2024-08-02: 91247245 — SUSPENDED involving CRISPR Therapeutics AG
- 2023-09-29: 91247245 — P CHANGE OF CORRESP ADDRESS involving CRISPR Therapeutics AG
- 2023-09-29: 91247245 — P RESP TO BD ORDER/INQUIRY involving CRISPR Therapeutics AG